Annual savings of $10 million have been realized after Infina Connect’s A+KIDS registry was deployed to help NC Medicaid monitor safe use of antipsychotics in children ages 17 and under. Infina Connect’s A+KIDS registry implements a NC Medicaid policy that requires prescribers of certain antipsychotic drugs for children 17 and under to submit safety-related information about patients receiving those drugs.
With our A+KIDS registry, authorizations are immediately available to the pharmacy POS systems upon submittal of complete documentation. Authorization expiration dates take on- and off-label rules into account. The system reminds prescribers when A+KIDS authorizations are about to expire to ensure that safety documentation is updated and medications are re-authorized without interrupting the patient’s treatment.
The A+KIDS registry makes possible the collection of valuable safety information that would be impractical with paper forms and faxes. The data derived from the A+KIDS system is reviewed and analyzed for safety insights that can be presented back to the prescribing community. The clinical guidelines provided by the system help prescribers evaluate the appropriateness of these potent medicines.
In addition to these significant safety benefits, NC Medicaid reported an approximately 20% drop in prescriptions during the first year of system deployment and $10 million annual savings.